Amarin
AMRN | NASDAQ
$11.31
-$0.07 (-0.62%)
At close: Nov 16, 2026, 4:00 PM ET
$11.31
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-0.62%
(1D)No price chart data available for 1D timeframe.
Rating
35.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #642/1021 (Top 63%)
Key Statistics
Market Data
Market Cap $233.92M
1D Range
11.25 11.44
52W Range
11.25 16.98
Valuation (TTM)
PE -10.77
PB 0.53
EV/EBITDA 4.57
Valuation (NTM)
Forward PE 274.94
Forward PEG -0.15
Price Target $2.00
Cash Flow
FCF Yield 30.4%
SBC Adj. FCF Yield 33.2%
SBC Impact -9.2%
Margins
Gross Margin 40.5%
Operating Margin -14.0%
FCF Margin 40.4%
Growth (CAGR)
Revenue 3Y | 5Y -18.3% |
-21.9%
Dil EPS 3Y | 5Y 18.4% |
18.9%
FCF 3Y | 5Y 685.5% |
166.8%
Returns
ROA -3.0%
ROE -4.3%
ROIC -5.3%
Financial Health
Net Cash
$323.38M
Current Ratio 3.50
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several internat...
Sector Healthcare
Industry Drug Manufacturers - General
Employees 80
IPO Date Apr 1, 1993
Website www.amarincorp.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Oct 28, 2026
EPS
$0.01
Beat +112.14%
YoY:
+18.00% REV
$39.55M
Miss -9.63%
YoY:
-20.37%Next Earnings
Feb 24, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove AMRN